Strain Information | |
---|---|
Image | ![]() |
BRC No. | RBRC00894 |
Type | Transgene![]() |
Species | Mus musculus |
Strain name | C57BL/6-Tg(CAG-Aicda)B1Hon/HonRbrc |
Former Common name | AID-Tg line #B1 |
H-2 Haplotype | |
ES Cell line | |
Background strain | C57BL/6NCrSlc |
Appearance | black [a/a B/B C/C] |
Strain development | Developed by Drs. Tasuku Honjo and Il-mi Okazaki at Kyoto University in 2002. |
Strain description | AID, Activation-Induced cytidine Deaminase is a molecule which specifically expressed in B lymphocytes after antigen stimulation, and plays a central role in acquisition for B cell of antibody gene variety. The transgenic mice express mouse AID gene under the control of CAG promoter and show high incidence of T cell lymphomas and dysgenetic lesions of epithelium of respiratory bronchioles. |
Colony maintenance | Backcross to C57BL/6 (Hemizygote x C57BL/6CrSlc) |
References | Constitutive expression of AID leads to tumorigenesis. Okazaki I M, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K, Honjo T J. Exp. Med., 197, 1173-1181 (2003). 12732658 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Aicda MGI:1342279 | activation-induced cytidine deaminase | UN | Aicda | CAG promoter (CMV-IE enhancer, chicken beta-actin promoter, rabbit beta-globin genomic DNA) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | more 12 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | CAG promoter (CMV-IE enhancer, chicken beta-actin promoter, rabbit beta-globin genomic DNA), mouse Aicda cDNA |
Research application | Immunology and Inflammation Research |
Specific Term and Conditions | 1) The RECIPIENT shall use the BIOLOGICAL RESOURCE only for academic research for the purpose of publishing the research results. 2) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR and a citation of the following literature(s) designated by the DEPOSITOR are requested. J. Exp. Med., 197, 1173-1181 (2003). 3) RECIPIENT shall notify the PROVIDER upon filing a patent application claiming modification of the BIOLOGICAL RESOURCE or method(s) of manufacture or use(s) of the BIOLOGICAL RESOURCE. |
Depositor | Tasuku Honjo (Kyoto University) |
Strain Status | ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |